https://www.selleckchem.com/pr....oducts/pf-06463922.h
We developed a model for improving the prediction of survival outcome using postoperative Ki-67 value in combination with residual cancer burden (RC in patients with breast cancer (BC) who underwent neoadjuvant chemotherapy (NAC). We analyzed the data from BC patients who underwent NAC between 2010 and 2019 at Samsung Medical Center and developed our residual proliferative cancer burden (RPC model using semi-quantitative Ki-67 value and RCB class. The Cox proportional hazard model was used to develop our RPCB model according to
Aimer
Commentaire
Partagez
